Rhythm Pharmaceuticals, Inc. (RYTM) Discusses FDA Extension of PDUFA Goal Date for Setmelanotide in Hypothalamic Obesity - Slideshow (NASDAQ:RYTM) 2025-12-05

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...